The nuts and bolts of analgesic infusions for private general practice (Proceedings)
Aug 01, 2009
CVC IN KANSAS CITY PROCEEDINGS
Analgesics administered by intermittent bolus create broad swings in drug plasma levels. Constant rate intravenous infusions (CRIs) are manually controlled titratable infusions. CRIs establish more consistent plasma levels and better overall control of drug effects. Mu agonist opioids, lidocaine, and ketamine are the most frequently utilized analgesics providing an effective multimodal benefit with low potential for adverse events. While delivery is possible through a standard gravity drip set, most prefer the fine control provided by an IV fluid pump or syringe pump. Calculators are available to eliminate the worry associated with drug delivery calculations. Analgesic CRIs not only contribute to compassionate pain relief, they can also help contribute to a balanced anesthetic program, reducing maintenance agent requirements, frequently improving patient blood pressures and ventilation. This session will focus on the details of how you can easily integrate analgesic CRIs into daily practice in the primary care setting.
Overview of presentation
Drugs commonly delivered through CRIs include morphine, hydromorphone, fentanyl, ketamine, midazolam, lidocaine, and dexmedetomidine. The opioids provide titratable analgesia that benefits the patient at the peripheral and central levels. Nausea, clinically relevant bradycardia and respiratory depression are not expected at normal analgesic dose rates. Ketamine enhances analgesia via different mechanisms; NMDA antagonism reducing central sensitization, enhancing opioid analgesia, reducing the risk of opioid induced hyperalgesia and opioid tolerance as well as possible direct analgesia via the D2 dopamine receptors. Midazolam provides sedation and relaxation, central analgesia, as well as a MAC sparing effect that can be of major benefit for patients experiencing problematic isoflurane or sevoflurane induced hypotension. Lidocaine is capable of enhancing analgesia while providing anti-inflammatory, reperfusion, cerebral protectant and GI motility benefits. Dexmedetomidine is attractive as an anxiolytic as well as a tool for enhanced patient analgesia.
CRIs are most commonly delivered through the IV fluid bag route or directly using a syringe pump. The IV fluid bag route is attractive because it allows for precise delivery rates using equipment already available at most practices. The simplest method involves a single fluid bag providing both the drug delivery as well as the patient's fluid needs. The downside to this method is the inability to adjust the fluid rate without changing the drug delivery rate. To maximize the flexibility of this method you generally need to pick low to midrange drug dose rates so that adjustments in the patient's fluid need don't take you outside of recommended drug dose rates.
You can expand your flexibility by running separate fluid lines through different IV fluid pumps. In the two-pump model, the CRI drugs would be delivered at a very low rate (ex. 1 ml/kg/hr) while the patient's additional fluid needs are separately managed through the second line. This allows for greater flexibility of drug and fluid delivery but requires multiple pumps and multiport IV access.
The greatest level of flexibility is gained when each analgesic is delivered through its own IV fluid bag. This allows for variable adjustments of each drug independent of the other but requires the greatest equipment resources and IV access ports.
While the calculations of the various CRI delivery options may seem daunting, this headache has been eliminated by easy to use calculators directly available online. These calculators allow you to vary the IV fluid bag size, fluid delivery rate, and drug dose rates to satisfy any conceivable combination.
Although the author does not generally recommend using gravity administration for analgesic CRIs this may be a consideration in some settings. Delivering gravity administered CRIs through a buretrol maximizes control over drug delivery while also setting a limit to the maximum amount of drug delivered.